225 related articles for article (PubMed ID: 22473575)
21. Local recurrence after total or subtotal esophagectomy for esophageal cancer.
Blewett CJ; Miller JD; Ramlawi B; Young JE; BennettWF ; Urschel JD
J Exp Clin Cancer Res; 2001 Mar; 20(1):17-9. PubMed ID: 11370823
[TBL] [Abstract][Full Text] [Related]
22. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
24. Impact of lymph node involvement in T2 or T3 thoracic esophageal squamous cell carcinoma.
Shimada H; Okazumi S; Shiratori T; Akutsu Y; Matsubara H
Hepatogastroenterology; 2009; 56(93):1039-43. PubMed ID: 19760937
[TBL] [Abstract][Full Text] [Related]
25. Predicting early cancer-related deaths after curative esophagectomy for esophageal cancer.
Matsumoto S; Takayama T; Wakatsuki K; Enomoto K; Tanaka T; Migita K; Ito M; Nakajima Y
Am Surg; 2013 May; 79(5):528-33. PubMed ID: 23635590
[TBL] [Abstract][Full Text] [Related]
26. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
27. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
28. Nodal skip metastasis is not a predictor of survival in thoracic esophageal squamous cell carcinoma.
Zhu Z; Yu W; Li H; Zhao K; Zhao W; Zhang Y; Sun M; Wei Q; Chen H; Xiang J; Fu X
Ann Surg Oncol; 2013 Sep; 20(9):3052-8. PubMed ID: 23686016
[TBL] [Abstract][Full Text] [Related]
29. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
[TBL] [Abstract][Full Text] [Related]
30. Outcome of low-volume surgery for esophageal cancer in a high-volume referral center.
Courrech Staal EF; van Coevorden F; Cats A; Aleman BM; van Velthuysen ML; Boot H; Peeters MJ; van Sandick JW
Ann Surg Oncol; 2009 Dec; 16(12):3219-26. PubMed ID: 19777184
[TBL] [Abstract][Full Text] [Related]
31. Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor.
Tong DK; Law S; Kwong DL; Chan KW; Lam AK; Wong KH
Ann Surg Oncol; 2010 Aug; 17(8):2184-92. PubMed ID: 20217248
[TBL] [Abstract][Full Text] [Related]
32. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy.
Tanaka T; Matono S; Mori N; Shirouzu K; Fujita H
Ann Surg Oncol; 2014 Mar; 21(3):932-8. PubMed ID: 24232603
[TBL] [Abstract][Full Text] [Related]
33. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
Chen G; Wang Z; Liu XY; Liu FY
Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
[TBL] [Abstract][Full Text] [Related]
35. Should stage T2 esophageal squamous cell carcinoma be subclassified?
Guo W; Xiao HL; Ma Z; Liu HJ; Wang YJ; Mei LY; Liu XH; Jiang YG; Wang RW
Ann Surg Oncol; 2014 Aug; 21(8):2540-5. PubMed ID: 24633669
[TBL] [Abstract][Full Text] [Related]
36. [Survival of patients with esophageal cancer subjected to total thoracic esophagectomy].
Braghetto I; Csendes A; Cornejo A; Amat J; Cardemil G; Burdiles P; Korn O
Rev Med Chil; 2000 Jan; 128(1):64-74. PubMed ID: 10883524
[TBL] [Abstract][Full Text] [Related]
37. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
38. Survival and clinical evaluation of salvage operation for cervical lymph node recurrence in esophageal cancer.
Komatsu S; Shioaki Y; Ichikawa D; Hamashima T; Kan K; Ueshima Y; Koide K; Lee CJ; Ikeda E; Mutoh F; Kurioka H; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):796-9. PubMed ID: 15966207
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery.
Yuequan J; Shifeng C; Bing Z
Ann Thorac Surg; 2010 Sep; 90(3):908-13. PubMed ID: 20732516
[TBL] [Abstract][Full Text] [Related]
40. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
Chao YK; Yeh CJ; Chang HK; Tseng CK; Chu YY; Hsieh MJ; Wu YC; Liu HP
Ann Surg Oncol; 2011 Feb; 18(2):529-34. PubMed ID: 20697822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
